The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multicenter observational study on re-evaluation of HER2 status in patients with HER2-positive advanced or recurrent gastric cancer refractory to trastuzumab.
 
Tomomi Kashiwada
No Relationships to Disclose
 
Hiroshi Saeki
Employment - Chugai Pharma
 
Yoshikazu Uenosono
No Relationships to Disclose
 
Akitaka Makiyama
No Relationships to Disclose
 
Masaaki Iwatsuki
No Relationships to Disclose
 
Yukiya Narita
Speakers' Bureau - Bristol-Myers Squibb; Chugai Pharma; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
Research Funding - Bristol-Myers Squibb; Ono Pharmaceutical
 
Hironaga Satake
Honoraria - Chugai Pharma; Taiho Pharmaceutical; Yakult Pharmaceutical
 
Yoshiko Matsuda
No Relationships to Disclose
 
Hideto Sonoda
No Relationships to Disclose
 
Eiji Oki
Speakers' Bureau - Bayer Yakuhin; Chugai Pharma; Lilly Japan; Merck Serono; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Yoshihiko Maehara
Speakers' Bureau - Chugai Pharma
Research Funding - Chugai Pharma